Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 7:35 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 649–672 of 6,915 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Stimulation Clear all

Conditions: Newly Diagnosed Ewing Sarcoma
Interventions: Cyclophosphamide, Doxorubicin, Vincristine, Ifosfamide, Etoposide, Surgery, Radiation Therapy*, Temozolomide, Irinotecan, Mesna, Dexrazoxane, G-CSF; Drug · Device · Procedure + 1 more
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 1 Year to 40 Years
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2027
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Vestibular Function Tests, Sensorimotor Performance
Interventions: Low-frequency noisy galvanic vestibular stimulation (nGVS), High-frequency noisy galvanic vestibular stimulation (nGVS); Device
Lead sponsor: National Aeronautics and Space Administration (NASA); Federal
Eligibility: 22 Years and older
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations
Interventions: Crenolanib, Cytarabine, Mitoxantrone, Placebo Oral Tablet, Fludarabine, Idarubicin, G-CSF; Drug
Lead sponsor: Arog Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 9
States / cities: Sacramento, California • Gainesville, Florida • Chicago, Illinois + 4 more

Conditions: Healthy, Insulin Resistance
Interventions: Neuromuscular Test, DEXA, Mixed Meal Tolerance Test, Strength Test; Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 60 Years to 85 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Traumatic Brain Injury, Upper Extremity
Interventions: taVNS, FTP; Device · Other
Lead sponsor: Craig Hospital; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Englewood, Colorado

Conditions: Fear Anxiety, PTSD
Interventions: Fear conditioning; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 50 Years
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 2
States / cities: Austin, Texas

Conditions: Aphasia
Interventions: Repetitive Transcranial Magnetic Stimulation, Sham TMS; Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 75 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Detrusor Overactivity
Interventions: Not listed
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Posttraumatic Stress Disorder (PTSD), Intrinsic and Novelty-related Sensory Cortical (SC) Disinhibition
Interventions: Alternating Current Stimulation (tACS), Sham for Transcranial Alternating Current Stimulation (tACS), Transcranial Random Noise stimulation (tRNS); Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 50 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia, Myelodysplasia
Interventions: human myeloid progenitor cells, G-CSF; Biological · Drug
Lead sponsor: Cellerant Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 10
States / cities: La Jolla, California • San Francisco, California • Stanford, California + 7 more

Conditions: Parkinson's Disease
Interventions: Deep Brain Stimulation, DBS surgery; Device · Procedure
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Nephrotic Syndrome in Children, Minimal Change Disease, Focal Segmental Glomerulosclerosis
Interventions: Transcutaneous auricular vagus nerve stimulation, Sham device; Device
Lead sponsor: Northwell Health; Other
Eligibility: 3 Years to 17 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: New Hyde Park, New York • Philadelphia, Pennsylvania

Conditions: Spinal Cord Injury
Interventions: D-Cycloserine, Placebo, Training, Stimulation, Placebo Stimulation; Drug · Other
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 18 Years to 85 Years
Enrollment: 257 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Papillary Thyroid Cancer
Interventions: Molecular Analysis for Thyroid Resection; Procedure
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Stroke
Interventions: human chorionic gonadotropin (hCG), then epoetin alfa (EPO), Saline Placebo; Drug
Lead sponsor: Stem Cell Therapeutics Corp.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Orange, California

Conditions: Stress Urinary Incontinence
Interventions: Electric DN, NM Re-ed, Exercise; Other
Lead sponsor: Alabama Physical Therapy & Acupuncture; Other
Eligibility: 35 Years and older · Female only
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Multiple Myeloma, Hodgkin Disease, Non-Hodgkin Lymphoma
Interventions: Acupuncture, opioid, Assessments; Other · Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 299 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 2
States / cities: New York, New York • Seattle, Washington

Conditions: Spinal Cord Injury Cervical
Interventions: Activity based upper extremity training with and without stimulation; Device
Lead sponsor: University of Louisville; Other
Eligibility: 7 Years to 12 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Critical Illness
Interventions: Muscle Ultrasound, Nerve Conduction Study, Electromyography; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Stroke, Depression - Major Depressive Disorder, Walking Impairment
Interventions: rTMS, AEx; Device · Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 21 Years and older
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 2
States / cities: Durham, North Carolina • Charleston, South Carolina

Conditions: Depressive Disorder, Major
Interventions: Active Cervel Neurotech Multi-Coil Transcranial Magnetic Stimulator, Inactive Cervel Neurotech Multi-Coil Transcranial Magnetic Stimulator; Device
Lead sponsor: Cervel Neurotech, Inc.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 6
States / cities: Atlanta, Georgia • Baltimore, Maryland • Lebanon, New Hampshire + 3 more

Conditions: Anemia
Interventions: methoxy polyethylene glycol-epoetin beta [Mircera]; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 137 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2005
U.S. locations: 6
States / cities: Los Angeles, California • San Jose, California • Boston, Massachusetts + 3 more

Conditions: Obsessive-Compulsive Disorder
Interventions: ERP plus tDCS, ERP plus sham tDCS; Other
Lead sponsor: Butler Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2015
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Obsessive-Compulsive Disorder
Interventions: Stereoencephalography (SEEG), Deep Brain Stimulation (DBS); Device
Lead sponsor: Casey H. Halpern, M.D.; Other
Eligibility: 22 Years to 75 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2030
U.S. locations: 2
States / cities: Stanford, California • Philadelphia, Pennsylvania

Search by objective public record fields.

Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma

Optimizing Noisy Galvanic Vestibular Stimulation Frequency Range for Enhancing Vestibular Perception and Manual Control Performance

Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML

A Comparison of Neuromuscular Recruitment in Trained and Untrained Adults

Transcutaneous Auricular Vagus Nerve Stimulation to Improve Upper Extremity Recovery After Traumatic Brain Injury

Neuroimaging Memories of Fear and Safety in the Human Brain

TMS in Aphasia Recovery

UNGF Assessment in Patients With Detrusor Overactivity Undergoing Sacral Neuromodulation

A Neurosensory Account of Anxiety and Stress (Study 1)

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia

Clinical Outcomes of Deep Brain Stimulator (DBS) Electrodes Placed Using Intraoperative Computed Tomography (CT) and Frameless Stereotaxis

taVNS for FRNS in Children

Lower Limb Function After Spinal Cord Injury

Molecular Analysis for Precision Surgery in Thyroid Cancer Trial

Study of NTx®-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients

Neuromuscular Re-eduaction, Exercise and Electric Dry Needling vs. Neuromuscular Re-education and Exercise for Stress Urinary Incontinence

Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma

Noninvasive Spinal Stimulation to Restore Hand Function in Children With Spinal Cord Injury

The Diagnosis and Incidence of Critical Illness Polyneuromyopathy in Medical and Neurosurgical ICU Patients

Combining rTMS & Aerobic Exercise to Treat Depression and Improve Post-Stroke Walking

A Clinical Trial for the Treatment of Depression With Repetitive Transcranial Magnetic Stimulation (rTMS)

A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia.

Transcranial Direct Current Stimulation Augmented Exposure and Response Prevention for Obsessive-Compulsive Disorder

SEEG-Guided DBS for OCD